1
|
Dietl B, Sánchez I, Arcenillas P, Cuchi E, Gómez L, González de Molina FJ, Boix-Palop L, Nicolás J, Calbo E. Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes. Int J Antimicrob Agents 2017; 51:498-502. [PMID: 29158144 DOI: 10.1016/j.ijantimicag.2017.11.003] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2017] [Revised: 10/30/2017] [Accepted: 11/09/2017] [Indexed: 12/31/2022]
Abstract
Infections due to multidrug-resistant bacteria (MDR) are currently a clinical challenge, mainly in elderly patients. The antimicrobial spectrum, safety and efficacy of ceftolozane/tazobactam (C/T) make it an attractive option for the treatment of MDR bacterial infections beyond the indications approved to date. Here we report our experience with C/T in four cases of osteomyelitis and three cases of skin and soft-tissue infections due to extensively-drug-resistant Pseudomonas aeruginosa.
Collapse
Affiliation(s)
- B Dietl
- Infectious Diseases Unit, Internal Medicine Department, Hospital Universitari Mútua Terrassa, Plaza Dr. Robert 5, 08223 Terrassa, Barcelona, Spain.
| | - I Sánchez
- Infectious Diseases Unit, Internal Medicine Department, Hospital Universitari Mútua Terrassa, Plaza Dr. Robert 5, 08223 Terrassa, Barcelona, Spain
| | - P Arcenillas
- Pharmacy Department, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | - E Cuchi
- Department of Microbiology, CatLab, Barcelona, Spain
| | - L Gómez
- Infectious Diseases Unit, Internal Medicine Department, Hospital Universitari Mútua Terrassa, Plaza Dr. Robert 5, 08223 Terrassa, Barcelona, Spain
| | | | - L Boix-Palop
- Infectious Diseases Unit, Internal Medicine Department, Hospital Universitari Mútua Terrassa, Plaza Dr. Robert 5, 08223 Terrassa, Barcelona, Spain; Universitat Internacional de Catalunya, Barcelona, Spain
| | - J Nicolás
- Pharmacy Department, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | - E Calbo
- Infectious Diseases Unit, Internal Medicine Department, Hospital Universitari Mútua Terrassa, Plaza Dr. Robert 5, 08223 Terrassa, Barcelona, Spain; Universitat Internacional de Catalunya, Barcelona, Spain
| |
Collapse
|
2
|
Boix-Palop L, Nicolás C, Xercavins M, Riera M, Prim N, Freixas N, Pérez J, Calbo E. Bacillus species pseudo-outbreak: construction works and collateral damage. J Hosp Infect 2016; 95:118-122. [PMID: 27856013 DOI: 10.1016/j.jhin.2016.10.013] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2016] [Accepted: 10/10/2016] [Indexed: 11/18/2022]
Abstract
We describe the investigation and management of a pseudo-outbreak of Bacillus spp. bacteraemia associated with construction work in an emergency department (ED). During the pseudo-outbreak period 59 out of 3469 (1.7%) blood cultures yielded Bacillus spp. versus 24 out of 7628 (0.31%) in 2012. Material, surfaces, and air samples showed environmental contamination. Cases rapidly declined following the implementation of infection control measures and the end of construction. Construction works at the ED caused environmental contamination that most probably led to the pseudo-outbreak of Bacillus bacteraemia. In hospital settings, the lack of correctly implemented effective barriers during construction may place patients and healthcare providers at risk as well as lead to pseudo-outbreaks.
Collapse
Affiliation(s)
- L Boix-Palop
- Internal Medicine Department, Infectious Diseases Unit, Hospital Universitari Mútua Terrassa, Barcelona, Spain; Universitat Internacional de Catalunya, Barcelona, Spain.
| | - C Nicolás
- Infection Control Nurse, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | | | - M Riera
- Infection Control Nurse, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | - N Prim
- Microbiology Department, Hospital de Sant Pau, Barcelona, Spain
| | - N Freixas
- Infection Control Nurse, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | - J Pérez
- Microbiology, Catlab, Barcelona, Spain
| | - E Calbo
- Internal Medicine Department, Infectious Diseases Unit, Hospital Universitari Mútua Terrassa, Barcelona, Spain; Universitat Internacional de Catalunya, Barcelona, Spain
| |
Collapse
|